USE OF ECTEINASCIDIN IN THE TREATMENT OF CANCER IN PATIENTS WITH LOW LEVEL OF BRCA1
摘要
The present invention relates to the use of ecteinascidin 743 in patients having certain levels of molecular markers who can predict the outcome of chemotherapy, in particular in patients having low levels of BRCA1 expression.
申请公布号
WO2006005602(A3)
申请公布日期
2006.04.13
申请号
WO2005EP07605
申请日期
2005.07.11
申请人
PHARMA MAR, S.A., SOCIEDAD UNIPERSONAL;ROSELL COSTA, RAFAEL;TARON ROCA, MIGUEL;JIMENO DONAQUE, JOSE MA;TERCERO LOPEZ, JUAN CARLOS
发明人
ROSELL COSTA, RAFAEL;TARON ROCA, MIGUEL;JIMENO DONAQUE, JOSE MA;TERCERO LOPEZ, JUAN CARLOS
